Eli Lilly & Co. has faced a dramatic drop in its stock price, tumbling over 10% following a critical earnings report that highlighted missed revenue targets for two of its most anticipated drugs: Mounjaro, a diabetes medication, and Zepbound, a high-profile weight-loss drug. Investors, who had anticipated a robust sales report amid growing demand for […]
In a strategic move to tackle the growing diabetes crisis in the Middle East, Biocon Limited has announced a partnership with Tabuk Pharmaceutical Manufacturing Company. This alliance aims to commercialize Biocon’s Glucagon-like peptide-1 (GLP-1) products across the Middle East, specifically focusing on Saudi Arabia and neighboring regions. GLP-1 products, which are increasingly recognized for their […]
Shares of LifeVantage Corporation have jumped 8.2% after the company announced encouraging results from a study on its new two-product system designed to boost GLP-1 production. The stock, which was trading around $9.23, has risen by 51% so far this year. The study results have created a buzz in both the health and investment communities, […]